Generate Biomedicines GENB vs Competition GENB Latest Quarter Earnings Generate Biomedicines posts AI drug pipeline wins BTAI BioXcel posts narrower than expected Q4 2025 loss even as shares drop 364 percent in todays trading SAR Saratoga delivers 227 percent Q1 2026 EPS beat shares edge higher on positive investor sentiment Is TriCo Bancshares TCBK the most overlooked stock right now Motionless 20260508